Home Stock

Stock Research: Bio-Techne

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Bio-Techne

NSQ:TECH US09073M1045
96
  • Value
    76
  • Growth
    53
  • Safety
    Safety
    100
  • Combined
    96
  • Sentiment
    69
  • 360° View
    360° View
    96
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bio-Techne Corporation is a global life sciences company providing tools and reagents for research and diagnostics. It operates in the life sciences industry with segments including Protein Sciences and Diagnostics and Genomics. In the last fiscal year, the company had a market cap of $8,149 million, profits of $770 million, and revenue of $1,159 million, with 3,100 employees.

more

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Bio-Techne are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Bio-Techne. The consolidated Value Rank has an attractive rank of 76, which means that the share price of Bio-Techne is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 76% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 100. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 69. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Safety
Country USA
Industry Life Sciences Tools & Services
Size Large
Website bio-techne.com
Index
NASDAQ
D.J. US Health Care
S&P 500
Bio-Techne stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Jul-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
76 66 52 67
Growth
53 73 49 71
Safety
Safety
100 85 52 51
Sentiment
69 98 92 97
360° View
360° View
96 100 81 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
9 49 95 83
Opinions Change
26 85 50 50
Pro Holdings
n/a 90 53 91
Market Pulse
97 93 85 56
Sentiment
69 98 92 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
76 66 52 67
Growth
53 73 49 71
Safety Safety
100 85 52 51
Combined
96 100 55 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
42 19 15 27
Price vs. Earnings (P/E)
15 32 27 20
Price vs. Book (P/B)
34 34 27 20
Dividend Yield
97 96 96 98
Value
76 66 52 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
23 54 58 41
Profit Growth
93 53 42 49
Capital Growth
26 68 39 67
Stock Returns
67 65 49 67
Growth
53 73 49 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
55 56 47 44
Refinancing
92 20 7 15
Liquidity
97 94 87 78
Safety Safety
100 85 52 51

Similar Stocks

Discover high‑ranked alternatives to Bio-Techne and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews